Search hospitals > New Jersey > Newark
Rutgers New Jersey Medical School
Claim this profileNewark, New Jersey 07103
Global Leader in HIV Infection
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Breast Cancer
Conducts research for Breast cancer
Conducts research for Tuberculosis
194 reported clinical trials
22 medical researchers
Summary
Rutgers New Jersey Medical School is a medical facility located in Newark, New Jersey. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Breast Cancer, Breast cancer, Tuberculosis and other specialties. Rutgers New Jersey Medical School is involved with conducting 194 clinical trials across 342 conditions. There are 22 research doctors associated with this hospital, such as Howard S. Hochster, Eugenia Girda, MD, Missak Haigentz, MD, and Mridula George, MD.Top PIs
Howard S. HochsterRutgers Cancer Institute of New Jersey6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
17 reported clinical trials
37 drugs studied
Eugenia Girda, MDRutgers Cancer Institute of New Jersey5 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
16 reported clinical trials
31 drugs studied
Missak Haigentz, MDRutgers Cancer Institute of New Jersey4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
23 drugs studied
Mridula George, MDRutgers Cancer Institute of New Jersey2 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
38 drugs studied
Clinical Trials running at Rutgers New Jersey Medical School
Oropharyngeal Carcinoma
Prostate Cancer
Laryngeal Cancer
Kidney Cancer
Pulmonary Embolism
Uterine Cancer
Lip and Oral Cavity Cancer
Throat Cancer
Lung Cancer
Oral Squamous Cell Carcinoma
Ipatasertib + Chemoradiation
for Head and Neck Cancer
This trial tests the safety and best dose of ipatasertib combined with chemo-radiation in patients with advanced head and neck cancer. Ipatasertib may help stop or kill cancer cells by blocking a protein they need to grow. The goal is to see if this combination works better than chemo-radiation alone.
Recruiting1 award Phase 119 criteria
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rutgers New Jersey Medical School?
Rutgers New Jersey Medical School is a medical facility located in Newark, New Jersey. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Breast Cancer, Breast cancer, Tuberculosis and other specialties. Rutgers New Jersey Medical School is involved with conducting 194 clinical trials across 342 conditions. There are 22 research doctors associated with this hospital, such as Howard S. Hochster, Eugenia Girda, MD, Missak Haigentz, MD, and Mridula George, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.